These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31097)

  • 1. Baclofen in the treatment of tardive dyskinesia.
    Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen in tardive dyskinesia patients maintained on neuroleptics.
    Stewart RM; Rollins J; Beckham B; Roffman M
    Clin Neuropharmacol; 1982 Dec; 5(4):365-73. PubMed ID: 6130838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen in the treatment of tardive dyskinesia and schizophrenia.
    Simpson GM; Lee JH; Shrivastava RK; Branchey MH
    Psychopharmacol Bull; 1978 Apr; 14(2):16-8. PubMed ID: 349598
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J
    Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen in Parkinson's disease.
    Lees AJ; Shaw KM; Stern GM
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):707-8. PubMed ID: 355602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia.
    Lancet; 1979 Sep; 2(8140):447-8. PubMed ID: 89504
    [No Abstract]   [Full Text] [Related]  

  • 10. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of tardive dyskinesia with baclofen.
    Glazer WM; Moore DC; Bowers MB; Bunney BS; Roffman M
    Psychopharmacology (Berl); 1985; 87(4):480-3. PubMed ID: 3936106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of baclofen against placebo in the treatment of schizophrenia.
    Gulmann NC; Bahr B; Andersen B; Eliassen HM
    Acta Psychiatr Scand; 1976 Oct; 54(4):287-93. PubMed ID: 793304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dystonia: four case histories.
    Yadalam KG; Korn ML; Simpson GM
    J Clin Psychiatry; 1990 Jan; 51(1):17-20. PubMed ID: 1967246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.